The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies
Open accessAbstract
Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1 A (DYRK1A ) is a highly conserved gene located in the Down syndrome critical region. It has an important role in early development and regulation of neuronal proliferation. Microdeletions of chromosome 21q22.12q22.3 that include DYRK1A (21q22.13) are rare and only a few pathogenic single-nucleotide variants (SNVs) in the DYRK1A gene have been described, so as of yet, the landscape of DYRK1A disruptions and their associated phenotype has not been fully explored. We have identified 14 individuals with de novo heterozygous variants of DYRK1A; five with microdeletions, three with small insertions or deletions (INDELs) and six with deleterious SNVs. The analysis of our cohort and comparison with published cases reveals that phenotypes are consistent among individuals with the 21q22.12q22.3 microdeletion and those with translocation, SNVs, or INDELs within DYRK1A. All individuals shared congenital microcephaly at birth, intellectual disability, developmental delay, severe speech impairment, short stature, and distinct facial features. The severity of the microcephaly varied from -2 SD to -5 SD. Seizures, structural brain abnormalities, eye defects, ataxia/broad-based gait, intrauterine growth restriction, minor skeletal abnormalities, and feeding difficulties were present in two-thirds of all affected individuals. Our study demonstrates that haploinsufficiency of DYRK1A results in a new recognizable syndrome, which should be considered in individuals with Angelman syndrome-like features and distinct facial features. Our report represents the largest cohort of individuals with DYRK1A disruptions to date, and is the first attempt to define consistent genotype-phenotype correlations among subjects with 21q22.13 microdeletions and DYRK1A SNVs or small INDELs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in DYRK1A and TCF4 cause syndromic diseases presenting with microcephaly and intellectual disability97–105.”
From Distinct selective forces and Neanderthal introgression shaped genetic diversity at genes involved in neurodevelopmental disorders (2017) · cites this paper as [101]
In the citing paper
“For both genes haploinsufficiency is often associated with disease, indicating that adequate expression levels of these proteins are essential for neurodevelopment98, 101, 106.”
From Distinct selective forces and Neanderthal introgression shaped genetic diversity at genes involved in neurodevelopmental disorders (2017) · cites this paper as [101]
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Chromosomal microarray versus karyotyping for prenatal diagnosis
Wapner, R. J., Martin, C. L., Levy, B., Ballif, B. C., Eng, C. M., Zachary, J. M., Savage, M., Platt, L. D., Saltzman, D., Grobman, W. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203382 · Cited by 1,412
Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders
Lee, H., Deignan, J. L., Dorrani, N., Strom, S. P., Kantarci, S., Quintero‐Rivera, F., Das, K., Toy, T. L., Harry, B., Yourshaw, M., et al. (2014) · JAMA · doi:10.1001/jama.2014.14604 · Cited by 991
Self-citationThe Structural Basis for Control of Eukaryotic Protein Kinases
Endicott, J., Noble, M. E. M., & Johnson, L. N. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052410-090317 · Cited by 440
minibrain: A new protein kinase family involved in postembryonic neurogenesis in Drosophila
Tejedor, F. J., Zhu, X., Kaltenbach, E., Ackermann, A., Baumann, A., Canal, I., Heisenberg, M., Fischbach, K. F., & Pongs, O. (1995) · Neuron · doi:10.1016/0896-6273(95)90286-4 · Cited by 379
Fotaki, V., Dierssen, M., Alcántara, S., Martínez, S., Martí, E., Casas, C., Visa, J., Soriano, E., Estivill, X., & Arbonés, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6636-6647.2002 · Cited by 344
Activation-Loop Autophosphorylation Is Mediated by a Novel Transitional Intermediate Form of DYRKs
Lochhead, P. A., Sibbet, G. J., MORRICE, N. A., & Cleghon, V. (2005) · Cell · doi:10.1016/j.cell.2005.03.034 · Cited by 330
Aranda, S., Laguna, A., & de la Luna, S. (2011) · The FASEB Journal · doi:10.1096/fj.10-165837 · Cited by 320
de la Torre, R., Sola, S. D., Pons‐Espinal, M., Duchon, A., de Lagrán, M. M., Farré, M., Fitó, M., Benejam, B., Langohr, K., Rodríguez, J. C., et al. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300325 · Cited by 297
Becker, W. B., Weber, Y. G., Wetzel, K., EIRMBTER, K., Tejedor, F. J., & Joost, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25893 · Cited by 285
Kentrup, H., Becker, W. B., Heukelbach, J., Wilmes, A., Schürmann, A., Huppertz, C., Kainulainen, H., & Joost, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3488 · Cited by 259
Activation, regulation, and inhibition of DYRK1A
Becker, W. B., & Sippl, W. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07956.x · Cited by 225
MNB/DYRK1A as a multiple regulator of neuronal development
Tejedor, F. J., & Hämmerle, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07954.x · Cited by 214
BDNF Selectively Regulates GABA A Receptor Transcription by Activation of the JAK/STAT Pathway
Lund, I. V., Hu, Y., Raol, Y. H., Benham, R. S., Faris, R., Russek, S. J., & Brooks‐Kayal, A. R. (2008) · Science Signaling · doi:10.1126/scisignal.1162396 · Cited by 181
Song, W., Sternberg, L. R., Kasten-Sportès, C., Keuren, M. L. V., Chung, S.-H., Slack, A. C., Miller, D. E., Glover, T. W., Chiang, P.-W., Lou, L., et al. (1996) · Genomics · doi:10.1006/geno.1996.0636 · Cited by 177
Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly
Møller, R. S., Kübart, S., Hoeltzenbein, M., Heye, B., Vogel, I., Hansen, C. P., Menzel, C., Ullmann, R., Tommerup, N., Ropers, H.-H., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.03.001 · Cited by 163
The Down Syndrome critical region
Shapiro, B. L. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_3 · Cited by 149
Lepagnol-Bestel, A.-M., Zvara, Á., Maussion, G., Quignon, F., Ngimbous, B., Ramoz, N., Imbeaud, S., Loe-Mie, Y., Benihoud, K., Agier, N., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp047 · Cited by 143
Chromosomal Microarray Versus Karyotyping for Prenatal Diagnosis
Wapner, R. J., Martin, C. L., Levy, B., Ballif, B. C., Eng, C. M., Zachary, J. M., Savage, M. S., Platt, L. D., Saltzman, D. H., Grobman, W. A., et al. (2013) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000429294.57890.b8 · Cited by 134
Hong, S.-H., Lee, K., Kwak, S., Kim, A., Bai, H., Jung, M., Kwon, O., Song, W., Tatar, M., & Yu, K. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002857 · Cited by 123
Courcet, J.-B., Faivre, L., Malzac, P., Masurel-Paulet, A., Lopez, E., Callier, P., Lambert, L., Lemesle, M., Thevenon, J., Gigot, N., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101251 · Cited by 121
Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly
van Bon, B., Hoischen, A., Hehir-Kwa, J., de Brouwer, A., Ruivenkamp, C., Gijsbers, A., Marcelis, C., de Leeuw, N., Veltman, J., Brunner, H., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01544.x · Cited by 117
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage
Souchet, B., Guedj, F., Sahún, I., Duchon, A., Daubigney, F., Badel, A., Yanagawa, Y., Barallobre, M. J., Dierssen, M., Yu, E. Y., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.016 · Cited by 117
Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/− mouse
Benavides‐Piccione, R., Dierssen, M., Ballesteros‐Yáñez, I., de Lagrán, M. M., Arbonés, M. L., Fotaki, V., DeFelipe, J., & Elston, G. N. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.004 · Cited by 98
Dierssen, M., & de Lagrán, M. M. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.319 · Cited by 97
Kelly, P. A., & Rahmani, Z. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1085 · Cited by 86
Chen, C., Brégère, C., Paluch, J., Lu, J. F., Dickman, D. K., & Chang, K. T. (2014) · Nature Communications · doi:10.1038/ncomms5246 · Cited by 77
Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis
Lee, Y., Ha, J., Kim, H. J., Kim, Y.-S., Chang, E., Song, W., & Kim, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042234 · Cited by 76
Mechanism of dual specificity kinase activity of DYRK 1 A
Walte, A., Rüben, K., Birner‐Gruenberger, R., Preisinger, C., Bamberg‐Lemper, S., Hilz, N., Bracher, F., & Becker, W. B. (2013) · FEBS Journal · doi:10.1111/febs.12411 · Cited by 75
Valetto, A., Orsini, A. A., Bertini, V., Toschi, B., Bonuccelli, A., Simi, F., Sammartino, I., Taddeucci, G., Simi, P., & Saggese, G. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.03.011 · Cited by 68
Prenatal treatment of Down syndrome
Guedj, F., Bianchi, D. W., & Delabar, J. M. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000056 · Cited by 62
Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6
Yamamoto, T., Shimojima, K. Y., Nishizawa, T., Matsuo, M., Ito, M., & Imai, K. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33735 · Cited by 56
Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome
Laguna, A., Barallobre, M. J., Marchena, M., Mateus, C., Ramírez, E., Martínez‐Cué, C., Delabar, J. M., Castelo-Branco, M. S., de la Villa, P., & Arbonés, M. L. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt125 · Cited by 54
Izumi, K., Brooks, S. S., Feret, H. A., & Zackai, E. H. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35368 · Cited by 52
Self-citationDistinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A
Oegema, R., de Klein, A., Verkerk, A. J. M. H., Schot, R., Dumee, B., Douben, H., Eussen, B. J. F. M. M., Dubbel, L., Poddighe, P. J., van der Laar, I., et al. (2010) · Molecular Syndromology · doi:10.1159/000320113 · Cited by 49
Unusual function of the activation loop in the protein kinase DYRK1A
Wiechmann, S., Czajkowska, H., de Graaf, K., Grötzinger, J., Joost, H., & Becker, W. B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00148-7 · Cited by 45
Berto, G. E., Iobbi, C., Camera, P., Scarpa, E., Iampietro, C., Bianchi, F. T., Gai, M., Sgrò, F., Cristofani, F., Gärtner, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093721 · Cited by 38
Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass
Rachdi, L., Kariyawasam, D., Guez, F., Aïello, V., Arbonés, M. L., Janel, N., Delabar, J. M., Polak, M., & Scharfmann, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3174-3 · Cited by 38
Microdeletion of the Down syndrome critical region at 21q22
Fujita, H., Torii, C., Kosaki, R., Yamaguchi, S., Kudoh, J., Hayashi, K., Takahashi, T., & Kosaki, K. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33228 · Cited by 33
Abekhoukh, S., Planque, C., Ripoll, C., Urbaniak, P., Paul, J., Delabar, J., & Janel, N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8326-1 · Cited by 32
Boku, S., Nakagawa, S., Takamura, N., Kato, A., Takebayashi, M., Hisaoka-Nakashima, K., Omiya, Y., Inoue, T., & Kusumi, I. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.011 · Cited by 31
McMillan, E., Kamps, A. L., Lake, S. S., Svendsen, C. N., & Bhattacharyya, A. (2012) · PubMed Central · Cited by 15
De Novo 21q22.1q22.2 deletion including RUNX1 mimicking a congenital infection
Thévenon, J., Callier, P., Thauvin‐Robinet, C., Méjean, N., Falcon‐Eicher, S., Maynadié, M., de Maistre, E., Bidot, S., Huet, F., Béri‐Dexheimer, M., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33809 · Cited by 12
Strom, S. P., & Gorin, M. B. (2013) · PubMed · Cited by 11
Flagged first, then by citations
Cited by
Sorted by citations
Advancing the understanding of autism disease mechanisms through genetics
de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016) · Nature Medicine · doi:10.1038/nm.4071 · Cited by 827
Autism genetics: opportunities and challenges for clinical translation
Vorstman, J. A. S., Parr, J. R., Moreno‐De‐Luca, D., Anney, R., Nürnberger, J. I., & Hallmayer, J. F. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.4 · Cited by 517
Down syndrome and the complexity of genome dosage imbalance
Antonarakis, S. E. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.154 · Cited by 314
Optical genome mapping enables constitutional chromosomal aberration detection
Mantere, T., Neveling, K., Pebrel‐Richard, C., Benoist, M., van de Zande, G., Kater‐Baats, E., Baatout, I., van Beek, R., Yammine, T., Oorsprong, M., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.05.012 · Cited by 256
Genomics, convergent neuroscience and progress in understanding autism spectrum disorder
Willsey, H. R., Willsey, A. J., Wang, B., & State, M. W. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00576-7 · Cited by 239
Metadata
- Authors
- Ji, J., Lee, H., Argiropoulos, B., Dorrani, N., Mann, J., Martinez-Agosto, J. A., Gomez-Ospina, N., Gallant, N., Bernstein, J. A., Hudgins, L., Slattery, L., Isidor, B., Le Caignec, C., David, A., Obersztyn, E., Wiśniowiecka-Kowalnik, B., Fox, M., Deignan, J. L., Vilain, E., Hendricks, E., Horton Harr, M., Noon, S. E., Jackson, J. R., Wilkens, A., Mirzaa, G., Salamon, N., Abramson, J., Zackai, E. H., Krantz, I., Innes, A. M., Nelson, S. F., Grody, W. W., & Quintero-Rivera, F.
- Affiliations
- University of California, Los Angeles (US)
- University of Calgary (CA)
- Kaiser Permanente (US)
- Stanford Medicine (US)
- Inserm (FR)
- Instytut Matki i Dziecka (PL)
- Seattle Children's Research Institute (US)
- Children's Hospital of Philadelphia (US)
- Tata Institute of Fundamental Research (IN)
- ORCID
- Venue
- European Journal of Human Genetics
- Published
- 2015-05-06
- Volume
- 23
- Issue
- 11
- Pages
- 1473-1481
- ISSN
- 1018-4813 (ISSN-L)
- 1476-5438
- PMC
- PMC4613469
- OpenAlex
- W1520236834
- Cited by
- 145
- References
- 46
- Citations by year
- 2026: 14 · 2025: 8 · 2024: 20 · 2023: 19 · 2022: 12 · 2021: 25 · 2020: 10 · 2019: 8 · 2018: 8 · 2017: 13 · 2016: 7 · 2015: 1
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (GM078844, R01GM078844)
- National Institute of Neurological Disorders and Stroke (K08NS092898)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Keywords
- DYRK1A, haploinsufficiency, Down syndrome critical region, microcephaly, intellectual disability, speech disorders, facial dysmorphism, genotype-phenotype correlation, de novo mutations, seizures, developmental delay, short stature
- MeSH terms
- Abnormalities, Multiple, Dyrk Kinases, Chromosome Deletion, Down Syndrome, Female, Humans, Male, Intellectual Disability, Microcephaly, Phenotype, Protein-Tyrosine Kinases, Protein Serine-Threonine Kinases, Facies, Polymorphism, Single Nucleotide, Haploinsufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
